140
Participants
Start Date
June 16, 2021
Primary Completion Date
May 23, 2022
Study Completion Date
June 22, 2022
Meglumine Sodium Succinate
500 ml of 1.4% solution IV at a rate of at least 4 ml and not more than 10 ml per minute
Placebo
Ringer's solution, 500 ml IV at a rate of at least 4 ml and not more than 10 ml per minute
Ivanovo Regional Clinical Hospital, Ivanovo
"GBUZ Arkhangelsk region First GKB named after E.E. Volosevich", Arkhangelsk
National Research Mordovian State University n.a. N.P. Ogarev, Saransk
Privolzhsky District Medical Center, Nizhny Novgorod
Central Clinical Hospital with a polyclinic of the Office of the President of the Russian Federation, Moscow
Saint-Petersburg I.I.Dzanelidze Research Institute of Emergency Medicine, Saint Petersburg
Atlant Clinical Ltd.
OTHER
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY